Nasdaq - Delayed Quote USD

Franklin Biotechnology Discovery A (FBDIX)

130.83 +1.64 (+1.27%)
As of 8:06 AM EDT. Market Open.

Top 10 Holdings (40.11% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 6.77%
REGN
Regeneron Pharmaceuticals, Inc. 6.30%
VRTX
Vertex Pharmaceuticals Incorporated 5.24%
ASND
Ascendis Pharma A/S 4.05%
INFXX
Institutional Fiduciary Trust Money Market Fund 3.69%
GILD
Gilead Sciences, Inc. 3.12%
BIIB
Biogen Inc. 2.94%
AZN
AstraZeneca PLC 2.83%
ITCI
Intra-Cellular Therapies, Inc. 2.59%
JAZZ
Jazz Pharmaceuticals plc 2.58%

Sector Weightings

SectorFBDIX
Healthcare   98.72%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 3.90%
Stocks 95.99%
Bonds 0.00%
Others 0.11%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average FBDIX Category Average
Price/Earnings 0 24.55
Price/Book 0.22 5.28
Price/Sales 0.15 2.06
Price/Cashflow 0 17.54
Median Market Cap 7,804.24 34,862.81
3 Year Earnings Growth 0 32.48

Bond Holdings

Performance & Risk

YTD Return 2.97%
5y Average Return 6.08%
Rank in Category (ytd) 11
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.68
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family Franklin Templeton Investments
Net Assets 949.93M
YTD Return 11.47%
Yield 0.00%
Morningstar Rating
Inception Date Sep 15, 1997

Fund Summary

Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.

Related Tickers